2.000
+0,00%
2026-10-19
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +140.8% | -156.1% | 1 / 3 | +17.3% | +0.08 pp | +9.66 pp | -1.9% | 0.00 | — | 161 | +17,3% | 4,0 | +140,8% | — | -5.36 | — |
| Pts | 12 | 0 | 4 | 8 | 8 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 2.000 (close price on 2026-10-19)EPS (TTM): −208,0
Financial charts
1.Revenue & growth
VND bn161Q2/26
1.Revenue & growth
VND bn161Q2/26
2.Profit & growth
VND bn4,09Q2/26
3.Profit mix (Penman)
VND bn-7,99Q2/26
4.Margins & cost structure
%1.4%Q2/26
5.Returns & cash cycle
% · days-3.3%Q2/26
6.Earnings quality & cash
VND bn21,1Q2/26
7.Asset structure
VND bn468Q2/26
8.Funding & debt health
VND bn · times468Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %-9,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %110Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-305%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26